Skip to main content
Elsevier

Journals in Pharmaceutical science

  • World Patent Information

    • ISSN: 0172-2190
    • 5 Year impact factor: 2.8
    • Impact factor: 2.4
    World Patent Information is a journal dedicated to intellectual property (IP) information and its retrieval, documentation, classification, searching, analysis, and management. The journal aims to encompass the broad field of IP information while focusing on intellectual property rights (IPRs) associated with industrially applicable innovations and their management, analysis, policy, education, and the use of big-data analytics.World Patent Information publishes articles addressing best practices in legal and commercial patent searching and analysis. Topics include freedom-to-operate (FTO) and clearance searches; state-of-the-art searches; validity and invalidity searches; prior-art searches; technical landscaping; technology scouting; technology forecasting; patentability analyses; and competitive intelligence based on patent information.The journal also welcomes research on metadata associated with IPRs, including legal-status data, classification systems, and bibliographic information. Articles concerning IP documentation, information retrieval, classification, and information services and news from IP offices are also encouraged.Reviews of the state of the art in specific industries, e.g., reviews of patents, IPs, scientific and technical databases, and their applications, are particularly welcome.The journal also publishes research and review articles on information relating to non-patent IPRs, including copyrights, trademarks, utility models, registered designs, design rights, trade secrets, database rights, traditional knowledge, Indigenous knowledge, and geographical indications, particularly where these rights have impacts on technological innovations.Other areas of interest include best practices in IP data sources and searching; IP management; invention harvesting; IP intermediary service innovations; and the applications of advanced artificial intelligence (AI), machine learning (ML), language modeling, text and data mining to IP-related research.The journal welcomes research on information retrieval (IR) across all aspects of published IP information, e.g., textual, document, non-textual, numerical, and graphical information. Relevant topics include multilingual search; image search; retrieval from tables and non-textual information; and information extraction from patents, including mathematical formulae, chemical and biological information, plant-related data, and other structured or unstructured information.The journal encourages additional research areas including system evaluation and benchmarking, real data collections for information-retrieva... experiments, and best practices in IP information management.The journal covers IP management across patents and non-patent IPRs (e.g., trademarks, designs, copyrights, and trade secrets). Topics related to innovation management are relevant, including the impact of patent/IP management on innovation; the best practices of IP innovation processes and management. Technology management from an IP perspective is an important area of interest. Relevant topics include the characteristics and dynamics of technologies; IP portfolio benchmarking; IP valuation; geographic and technological analysis; patent expiries; and advanced market-, corporate-, and policy-level analyses.The journal also welcomes research on statistical analysis, business-method patenting, standards and standard-essential patents (SEPs), patent pools, and other emerging issues at the intersections of IP, technology, information, and innovation management.
    Subscriptions

  • Fitoterapia

    • ISSN: 0367-326X
    • 5 Year impact factor: 2.9
    • Impact factor: 2.9
    The Journal for the Study of Medicinal PlantsA Q1-ranked journal in the category of 'Agricultural and Biological Sciences' (Scopus).Fitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in six major areas:Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes Innovative analytical approaches for dereplication and standardization of bioactive extracts and metabolites from plant resources Identification of bioactivity in plant and fungal extracts and in their constituents Identification of biological targets and mechanism of activity of plant and fungal extracts Production and genomic characterization of medicinal plants biomass Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues. Publication requirementsWestern Blots. Manuscripts reporting Western Blots must include original uncropped traces in triplicate as Supplementary Material. Images should be of good resolution.NMR data. Manuscripts reporting the structure elucidation of new compounds must include copies of MS and 1D and 2D NMR spectra as Supplementary Material. Fitoterapia strongly encourages Authors to deposit raw NMR data files (FID and 2D serial files) for new compounds in a publicly accessible data depository. Reviews. For review article submissions, Authors are required to provide evidence of their expertise and research experience in the specific field. Contributions reporting the following are NOT considered for publication: Activity data on crude extracts that have not been characterized by qualitative (and preferably quantitative) analysis of their individual constituents (LC/MS, or isolation followed by NMR). Data on the extract composition simply taken from literature or from previous studies are not acceptable. Characterization of only a few constituents is generally considered too partial. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. Unexceptional and predictable bioactivity (e.g. antioxidant and mild antimicrobial properties of phenolics or of essential oils). Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds.Studies based exclusively or mainly on computational/theore... investigations without adequate experimental support.In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal (e.g. investigation on extracts obtained from animal sources) RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified (with scientific Latin names), authenticated, and documented (voucher). RULE 4: Lack of the required supporting material (see publication requirements). RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature. RULE 7: Bibliometric or patentometric reviews.
    Subscriptions

  • Journal of Drug Delivery Science and Technology

    • ISSN: 1773-2247
    • 5 Year impact factor: 5.3
    • Impact factor: 5.2
    The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. It is the Offical Journal of the Association de Pharmacie Galenique Industrielle (APGI), Associazione Docenti e Ricercatori Italiani di Tecnologie e Legislazione Farmaceutiche (ADRITELF), and Academy of Pharmaceutical Science and Technology, Japan (APSTJ).The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on: • Controlled release • Bioavailability and drug absorption • Nanomedicines • Gene delivery • Tissue engineering, etc.Hot topics, related to manufacturing processes and quality control, are also welcomed.
    Subscriptions

  • Drug Resistance Updates

    • ISSN: 1368-7646
    • 5 Year impact factor: 23
    • Impact factor: 22
    Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.
    Subscriptions

  • International Journal of Pharmaceutics

    • ISSN: 0378-5173
    • 5 Year impact factor: 6.2
    • Impact factor: 6
    The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.
    Subscriptions